Talc induces apoptosis in human malignant mesothelioma cells in vitro

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 2 I, 2000, Pages 595-600

  Nasreen, Najmunnisa ^a   Mohammed, Kamal A ^a   Dowling, Patrick A ^a   Ward, Melissa J ^a   Galffy, Gabriella ^a   Antony, Veena B ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TALC;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA CLEAVAGE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALIGNANT MESOTHELIOMA; MESOTHELIUM CELL; PLEURA EFFUSION; PLEURODESIS; PRIORITY JOURNAL;

EID: 0034095376     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.2.9904123     Document Type: Article

References (36)

1. Hillerdal, G. 1982. Malignant mesothelioma: review of 4,710 published cases. Br. J. Dis. Chest 321-343.
2. Connelly, R. R., R. Spirtas, M. H. Myers, C. L. Percy, and J. F. Fraumeni, Jr. 1987. Demographic patterns for mesothelioma in the United State. J. Natl. Cancer Inst. 78:1053-1060.
3. Ribak, J., and I. J. Selikoff. 1992. Survival of asbestos insulation workers with mesothelioma. Br. J. Ind. Med. 49:732-735.
4. Antman, K. H. 1993. Natural history and epidemiology of malignant mesothelioma. Chest 103:373S-376S.
5. Sugarbaker, D. J., G. M. Strauss, T. J. Lynch, W. Richards, S. J. Mentzer, T. H. Lee, J. M. Corson, and K. H. Antman. 1993. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J. Clin. Oncol. 11:1172-1178.
6. Boutin, C., E. Nussbaum, and I. Monnet. 1994. Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma. Cancer 74:2460-2467.
7. Hausheer, F. H., and J. W. Yarbro. 1985. Diagnosis and treatment of malignant pleural effusions. Semin. Oncol. 12:54-77.
8. Rodriguez-Panadero, F., and V. B. Antony. 1997. State of the Art: pleurodesis. Eur. Respir. J. 10:1648-1654.
9. Hartman, D. L., J. M. Gaither, K. A. Kesler, J. W. Brown, and P. M. Mathur. 1992. Thoracoscopic talc pleurodesis with standard chest tube using tetracycline and bleomycin for control of malignant pleural effusions. J. Thorac. Cardiovas. Dis. 105:743-748.
10. Hartman, D. L., and V. B. Antony. 1993. Pleurodesis: now what should we do? J. Respir. Dis. 14:347-351.
11. Canto, A., J. Rivas, and J. Mayo. 1985. Pleural effusions of malignant etiology: thoracoscopic use of talc as an effective method of pleurodesis. Med. Clin. 84:806-808.
12. Broaddus, V. C., L. Yang, L. M. Scavo, J. D. Ernst, and A. M. Boylan. 1996. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J. Clin. Invest. 98:2050-2059.
13. Cohen, J. J., R. C. Duke, V. A. Fadok, and K. S. Sellins. 1992. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10:267-293.
14. Connell, N. D., and J. G. Rheinwald. 1983. Regulation of cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 34:245-253.
15. Han, D. K. M., C. C. Haudenschild, M. K. Hong, B. T. Tinkle, M. B. Leon, and G. Liau. 1995. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am. J. Pathol. 147:267-277.
16. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
17. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271-279.
18. McConkey, D. J., S. Orrnius, and M. Jondal. 1994. Cellular signaling in programmed cell death (apoptosis). Immunol. Today 11:120-121.
19. Wyllie, A. H. 1980. Glucocorticoid-induced thymocytes apoptosis is associated with endogenous endonuclease activity. Nature 284:555-556.
20. Kaufmann, S. H. 1989. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, campothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49: 5870-5878.
21. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
22. Sugarbaker, D. J. 1997. Multimodality therapy for malignant pleural mesothelioma. Chest 112:272s-275s.
23. Gamen, S., A. Anel, P. Lasierra, M. A. Alava, M. J. Martinez-Lorenzo, A. Pineiro, and J. Naval. 1997. Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way. FEBS Lett. 417:360-364.
24. Henkels, K. M., and J. J. Turchi. 1997. Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines. Cancer Res. 57:4488-4492.
25. Meyn, R. E., L. C. Stephens, N. R. Hunter, and L. Milas. 1995. Apoptosis in murine tumors treated with chemotherapy agents. Anticancer Drugs 6:443-450.
26. Rubins, J. B., T. Greatens, R. A. Kratzke, A. T. Tan, V. A. Polunovsky, and P. Bitterman. 1998. Lovastatin induces apoptosis in malignant mesothelioma cells. Am. J. Respir. Crit. Care Med. 157:1616-1622.
27. Rose, S. F., T. R. Bruce, P. Carmen, and W. S. George. Jr. 1997. Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells. J. Lab. Clin. Med. 130:530-534.
28. Van den Bogert, C., B. H. J. Dontje, and M. Holtrop. 1991. Arrest of the proliferation of renal and prostrate carcinomas of human origin by inhibition of mitochondrial protein synthesis. Cancer Res. 46:3283-3289.
29. 53 in alveolar macrophages (AM) characterizes the difference in murine strain response to bleomycin (BLM) (abstract). Am. J. Respir. Crit. Care Med. 151:A546.
30. Viallat, J. R., and C. Boutin. 1998, Malignant pleural effusions: recourse to early use of talc [French]. Rev. Med. Interne 19:811-818.
31. Hoffman, B., and D. A. Lieberman. 1998. The proto-oncogene c-myc and apoptosis. Oncogene 17:3351-3357.
32. Tan, A., H. Levrey, C. Dahm, V. A. Polunovsky, J. Rubins, and P. B. Bitterman. 1999. Lovastatin induces fibroblast apoptosis in vitro and in vivo: a possible therapy for fibroproliferative disorders. Am. J. Respir. Crit. Care Med. 159:220-227.
33. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243.
34. Ryan, J. J., R. Danish, C. A. Gottlieb, and M. F. Clarke. 1993. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol. Cell Biol. 13:711-719.
35. Hahne, M., D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L. E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, J. C. Cerottinin, and J. Tschopp. 1996. Melanoma cell expression of Fas (Apol/CD95) ligand: implications for tumor immune escape. Science 274:1363-1366.
36. Xerri, L., E. Devilard, J. Hassoun, P. Haddad, and F. Birg. 1997. Malignant and reactive cells from human lymphomas frequently express Fas ligand and display a different sensitivity to Fas-mediated apoptosis. Leukemias 11:1868-1877.